Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: A Study of the Safety, Engraftment, and Action of Multi-Dosed NB01 in Adults With Moderate Acne [Phase 1]
Phase 1 study assessing safety, engraftment, and action of multi-dosed NB01 in adults with acne vulgaris has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: DMT310-003 Topical in the Treatment of Acne Vulgaris [Phase 2]
Phase 2 trial update for DMT310-003 topical treatment in acne vulgaris has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: DMT310-001 Topical in the Treatment of Acne Vulgaris [Phase 2]
Phase 2 clinical trial update for DMT310-001 topical treatment in acne vulgaris has completed.
-
CLINICAL_TRIALS withdrawal · 2020-06-26Clinical Trial Update: Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1% [Phase 3]
Phase 3 bioequivalence study of Adapalene Gel 0.1% was withdrawn.
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris [Phase 3]
Phase 3 clinical trial comparing generic adapalene and benzoyl peroxide gel to Epiduo Forte for acne vulgaris has completed with results pos…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-06-18FDA Approved: ADAPALENE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' original generic application for adapalene, approving its use for acne vulgaris.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks [Phase 3]
Phase 3 trial assessing safety and efficacy of DFD-03 Lotion for acne vulgaris has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Decreasing Severity of Acne Vulgaris After the Use of a Combination of Anti-Acne Cream [Phase 1, Phase 2]
A combined anti-acne cream was studied in Phase 1 and Phase 2 trials for reducing severity of acne vulgaris; the study is completed.
-
CLINICAL_TRIALS trial_result · 2020-06-02Clinical Trial Update: A Study on Safety and Preliminary Efficacy of ALA in Acne Vulgaris [Phase 1, Phase 2]
Phase 1/2 trial assessing safety and preliminary efficacy of ALA in acne vulgaris has completed.
-
FDA approval · 2020-06-01FDA Approved: SEYSARA — Supplemental Application (Almirall, LLC)
The FDA approved a supplemental application for SEYSARA (sarecycline hydrochloride) submitted by Almirall, LLC.
-
CLINICAL_TRIALS trial_result · 2020-05-27Clinical Trial Update: Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris [Phase 3]
Phase 3 double-blind trial comparing generic clindamycin/benzoyl peroxide gel to Onexton gel in acne vulgaris completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-05-26Clinical Trial Update: A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris [Phase 3]
Phase 3 trial of DFD-03 for acne vulgaris completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-05-11Clinical Trial Update: A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris [Phase 3]
A Phase 3 study evaluating safety and therapeutic equivalence of Tazarotene Foam 0.1% in subjects with acne vulgaris has completed with resu…
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of an adapalene-clindamycin gel for acne vulgaris has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris [Phase 3]
A Phase 3 study comparing Test to Aczone 7.5% and to placebo in acne vulgaris has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-24Clinical Trial Update: Safety and Preliminary Efficacy of Combination Therapy for the Treatment of Acne Vulgaris [NA]
An update on a terminated clinical trial assessing safety and preliminary efficacy of a combination therapy for acne vulgaris, with results …
-
FDA approval · 2020-02-21FDA Approved: ACANYA — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for ACANYA (clindamycin phosphate and benzoyl peroxide) by Bausch Health US, LLC.
-
CLINICAL_TRIALS trial_result · 2020-02-21Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris [Phase 3]
Phase 3 trial update for topical FMX101 in moderate-to-severe acne vulgaris has completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris [Phase 4]
Phase 4 safety and efficacy trial of ACZONE (dapsone) gel 7.5% in children 9-11 with acne vulgaris has completed with posted results.
-
FDA approval · 2020-02-12FDA Approved: CLINDAMYCIN PHOAPHATE TOPICAL SOLUTION USP, 1% — Supplemental Application (Encube Ethicals, Inc.)
FDA approved a supplemental application for Clindamycin Phosphate Topical Solution USP, 1% (Encube Ethicals, Inc.) under an ANDA. This marks…
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris [Phase 2]
Phase 2 trial comparing CD2475/101 40 mg tablets to placebo and doxycycline for inflammatory lesions in acne vulgaris; results posted after …
-
FDA label_change · 2020-01-24FDA Approved: ABSORICA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ABSORICA (isotretinoin) by Sun Pharmaceutical Industries. The action updates the product lab…
-
CLINICAL_TRIALS trial_result · 2019-12-18Clinical Trial Update: Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris [Phase 3]
Phase 3 trial update on the efficacy and safety of IDP-121 and IDP-121 Vehicle Lotion for acne vulgaris.
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne [Phase 3]
Phase 3 trial update on subject-reported outcomes with adapalene 0.3% plus benzoyl peroxide 2.5% in dark skin acne (Acne Vulgaris) with comp…
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars [Phase 4]
Phase 4 clinical trial evaluating adapalene 0.3% - benzoyl peroxide 2.5% gel for acne vulgaris and atrophic acne scars has completed with re…